TrialThe Korean journal of hepatology2010

Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized study.

George K K Lau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.